Profit Or Loss [Abstract]

Zealand Pharma - Filing #1440145

Concept	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2018-01-01 to 2018-12-31	2018-01-01 to 2018-12-31	2018-01-01 to 2018-12-31	2018-01-01 to 2018-12-31	2018-01-01 to 2018-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue	—	—	353,314,000 DKK	—	—	—	—	—	41,333,000 DKK	—	—	—	—	37,977,000 DKK	—
Profit (loss) from operating activities	—	—	792,361,000 DKK	—	—	—	—	—	587,942,000 DKK	—	—	—	—	652,385,000 DKK	—
Finance income	—	—	2,022,000 DKK	—	—	—	—	—	14,655,000 DKK	—	—	—	—	9,988,000 DKK	—
Finance costs	—	—	49,314,000 DKK	—	—	—	—	—	3,390,000 DKK	—	—	—	—	37,322,000 DKK	—
Profit (loss) before tax	—	—	839,653,000 DKK	—	—	—	—	—	576,677,000 DKK	—	—	—	—	625,051,000 DKK	—
Tax expense (income)	—	—	7,076,000 DKK	—	—	—	—	—	5,136,000 DKK	—	—	—	—	43,773,000 DKK	—
Profit (loss)	846,729,000 DKK	0 DKK	846,729,000 DKK	0 DKK	0 DKK	0 DKK	0 DKK	571,541,000 DKK	571,541,000 DKK	0 DKK	0 DKK	0 DKK	581,278,000 DKK	581,278,000 DKK	0 DKK
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent	—	—	846,729,000 DKK	—	—	—	—	—	571,541,000 DKK	—	—	—	—	581,278,000 DKK	—
Earnings per share [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share	—	—	22.07	—	—	—	—	—	16.91	—	—	—	—	18.94	—
Diluted earnings per share [abstract]
Diluted earnings (loss) per share	—	—	22.07	—	—	—	—	—	16.91	—	—	—	—	18.94	—